Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -59.29% is 28% above its 5-year average of -82.47%, near the high end of its 5-year range (-926.44%–57.17%).
As of the fiscal period ended Tuesday, June 30, 2026. 80.27% above its 12-month average of -300.54%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -59.29%.
RETURN ON INVESTED CAPITAL (ROIC)
-59.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-300.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-96.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-82.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+80.27%
CURRENT VS 3Y AVG
+38.35%
CURRENT VS 5Y AVG
+28.11%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-66.25%
vs the sector median at left
Opus Genetics, Inc.
Market Cap
$361.64M
Return on Invested Capital (ROIC)
-59.29%
TTM Avg
-300.54%
3Y Avg
-96.16%
5Y Avg
-82.47%
Market Cap
$359.53M
Return on Invested Capital (ROIC)
-1.84%
TTM Avg
-2.07%
3Y Avg
-43.39%
5Y Avg
-53.01%
Market Cap
$355.43M
Return on Invested Capital (ROIC)
-27.16%
TTM Avg
-54.52%
3Y Avg
-49.44%
5Y Avg
-51.83%
Market Cap
$355.36M
Return on Invested Capital (ROIC)
11.00%
TTM Avg
8.68%
3Y Avg
7.86%
5Y Avg
11.51%
Market Cap
$353.88M
Return on Invested Capital (ROIC)
-24.20%
TTM Avg
-33.45%
3Y Avg
-34.14%
5Y Avg
-28.75%
Market Cap
$369.50M
Return on Invested Capital (ROIC)
-54.07%
TTM Avg
-33.14%
3Y Avg
-21.50%
5Y Avg
-27.82%
Market Cap
$353.00M
Return on Invested Capital (ROIC)
17.99%
TTM Avg
23.20%
3Y Avg
26.35%
5Y Avg
40.47%
Market Cap
$352.67M
Return on Invested Capital (ROIC)
-93.74%
TTM Avg
-188.84%
3Y Avg
-156.74%
5Y Avg
-129.07%
Market Cap
$349.70M
Return on Invested Capital (ROIC)
-56.73%
TTM Avg
-80.02%
3Y Avg
-65.94%
5Y Avg
-165.76%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Opus Genetics, Inc. (IRD) | $361.64M | -59.29% | -300.54% | -96.16% | -82.47% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | -1.84% | -2.07% | -43.39% | -53.01% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | -27.16% | -54.52% | -49.44% | -51.83% |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 11.00% | 8.68% | 7.86% | 11.51% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.88M | -24.20% | -33.45% | -34.14% | -28.75% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $369.50M | -54.07% | -33.14% | -21.50% | -27.82% |
| Embecta Corp. (EMBC)vs › | $353.00M | 17.99% | 23.20% | 26.35% | 40.47% |
| Ocugen, Inc. (OCGN)vs › | $352.67M | -93.74% | -188.84% | -156.74% | -129.07% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | -56.73% | -80.02% | -65.94% | -165.76% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $374.50M | -80.67% | -59.31% | -71.22% | -64.55% |
ROIC
-59.3%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -59.29% |
| 2026-03-31 | -74.91% |
| 2025-12-31 | -90.90% |
| 2025-09-30 | -926.44% |
| 2025-06-30 | -351.18% |
| 2025-03-31 | -268.84% |
| 2024-12-31 | -242.79% |
| 2024-09-30 | -85.93% |
| 2024-06-30 | -37.11% |
| 2024-03-31 | -26.36% |
| 2023-12-31 | -21.17% |
| 2023-09-30 | 57.17% |
| 2023-06-30 | 47.34% |
| 2023-03-31 | 44.35% |
| 2022-12-31 | 38.73% |
| 2022-09-30 | -186.36% |
| 2022-06-30 | -149.56% |
| 2022-03-31 | -137.40% |
| 2021-12-31 | -99.76% |
| 2021-09-30 | -148.68% |
| 2021-06-30 | -125.46% |
| 2021-03-31 | -228.39% |
| 2020-12-31 | -137.74% |
